Maverick Capital — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
Areteia Therapeutics was a clinical-stage biotechnology company that is no longer operating.
BiotechChapel Hill, US
Robin Walker(Executive Officer)inChristopher Courts(Executive Officer)Jorge Bartolome(Executive Officer, Director)
BoardBenjamin Gomez(Director)Adam Koppel(Director)inMichael E. Bozik(Director)
Co-investorsARCH Venture PartnersBain Capital Life SciencesGV (Google Ventures)Access BiotechnologySaturn PartnersViking Global Investors
Auradine develops ultra-low-power compute technology for AI applications across cloud data centers, edge, and physical/embodied AI.
AI & Machine LearningHardwareSemiconductorsCampbell, US
Barun Kar(Executive Officer, Director)in
BoardRajiv Khemani(Director)inNavin Chaddha(Director)inSriram Viswanathan(Director)Fred Thiel(Director)inSaid Ouissal(Director)
Co-investorsCleo CapitalAIspace VenturesCapricorn Investment GroupCelesta CapitalCota CapitalDCVC (Data Collective)+10 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.